What do systematic reviews say?

Adverse eventsPercentage of participants with any adverse event · patients undergoing knee arthroscopy

Adverse events Participants (n) withdrew due to adverse effects · patients with treating osteoarthritis

Adverse events Participants (n) reported serious adverse events · patients with treating osteoarthritis

Adverse events Participants (n) reported serious adverse events · patients with treating osteoarthritis

Adverse events Participants (n) withdrew due to adverse effects · patients with osteoarthritis of the knee

Adverse events Participants (n) reported serious adverse events · patients with osteoarthritis of the knee

Adverse events Participants (n) withdrew due to adverse effects · patients with osteoarthritis of the knee

Adverse events Participants (n) reported serious adverse events · patients with osteoarthritis of the knee

Withdrawals due to adverse events · patients with hand osteoarthritis

Adverse events Participants (n) reported serious adverse events · patients with hand osteoarthritis

Proportion of participants with 1 or more serious adverse events · chronic hepatitis B

Serious adverse events or complications of treatment — not reported

Adverse events: sepsis (as reported by study authors at end of study · critically ill adults admitted to the ICU for trauma, emergency, or post‐surgical care; population excludes participants with acute…

Adverse events None of the included studies evaluated adverse events · patients with acute low back pain

Adverse events None of the included studies evaluated adverse events · patients with acute LBP

Adverse events None of the included studies evaluated adverse events · patients with acute low back pain

Proportion of people with ≥ 1 serious adverse events during treatment · participants with unresectable hepatocellular carcinoma

Proportion of people with ≥ 1 serious adverse events during treatment · participants with unresectable hepatocellular carcinoma

Adverse events ‐ incidents of unspecified severe events ‐ medium term · Adults with co‐morbid PTSD and SMI

Adverse effects: measured adverse events ‐ medium term ‐ not measured · patients with schizophrenia